These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29874251)

  • 1. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
    Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
    PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.
    Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH
    Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
    Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
    Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
    Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving.
    Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM
    Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
    Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal
    Clausen FB
    Immunohematology; 2024 Apr; 40(1):15-27. PubMed ID: 38739027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
    Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
    BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
    Clausen FB; Barrett AN;
    Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
    Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
    Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
    Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
    Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma.
    Sedrak M; Hashad D; Adel H; Azzam A; Elbeltagy N
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):627-31. PubMed ID: 21488716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.
    Rouillac-Le Sciellour C; Puillandre P; Gillot R; Baulard C; Métral S; Le Van Kim C; Cartron JP; Colin Y; Brossard Y
    Mol Diagn; 2004; 8(1):23-31. PubMed ID: 15230639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots.
    Xiong Y; Jeronis S; Hoffman B; Liebermann DA; Geifman-Holtzman O
    Prenat Diagn; 2017 Apr; 37(4):311-317. PubMed ID: 28081297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.